InMode (InMode) Debt-to-Revenue : 0.02 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InMode Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

InMode's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.4 Mil. InMode's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $6.6 Mil. InMode's annualized Revenue for the quarter that ended in Dec. 2023 was $507.1 Mil. InMode's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.02.

InMode Debt-to-Revenue Historical Data

The historical data trend for InMode's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Debt-to-Revenue Chart

InMode Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.01

0.02

InMode Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.02

Competitive Comparison of InMode's Debt-to-Revenue

For the Medical Devices subindustry, InMode's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InMode's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InMode's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where InMode's Debt-to-Revenue falls into.

InMode Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

InMode's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.404	+	6.613)	/	492.048
	=	0.02

InMode's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.404	+	6.613)	/	507.124
	=	0.02

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

InMode Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of InMode's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

InMode (InMode) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

154:Germany 154:Germany

Address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206

Website

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.